Poster Presentations

Print
 
FOIU II
List of Posters
Board No.
Title
1
MULTI-PARAMETRIC MRI ENHANCES DETECTION OF SIGNIFICANT TUMOR IN PATIENTS ON ACTIVE SURVEILLANCE FOR PROSTATE CANCER
P.C. Black1, T. Walshe2, J. Aning1, A.C. Harris2, S.D. Chang2, A.I. So1, M.E. Gleave1, L. Machan2, S.L. Goldenberg1
1Urologic Sciences, University of British Columbia, Canada
2Radiology, University of British Columbia, Canada
2
MULTI-PARAMETRIC MRI-TARGETED BIOPSY FOR DETECTION OF PROSTATE CANCER IN PATIENTS WITH PRIOR NEGATIVE BIOPSIES
P.C. Black1, T. Walshe2, S.D. Chang2, M.E. Gleave1, A.C. Harris2, A.I. So1, S.L. Goldenberg1, L. Machan2
1Urologic Sciences, University of British Columbia, Canada
2Radiology, University of British Columbia, Canada
3
E. D. Crawford1, N. Shore2, C. Higano3, A. Neijber4, D. Marshall5, V. Yankov5
1University of Colorado, Aurora, USA
2Carolina Urologic Research Center, Myrtle Beach, USA
3Seattle Cancer Care Alliance, Seattle, USA
4Ferring Pharmaceuticals, Copenhagen, Denmark
5Ferring Pharmaceuticals, Parsippany−Troy Hills, USA
 
4
E. D. Crawford1, N. Shore2, L. Klotz3, K. Miller4, T. de Reijke5, A. Falkenberg6
1University of Colorado, Aurora, USA
2Carolina Urologic Research Center, Myrtle Beach, USA
3Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada
4Charité–Universitätsmedizin Berlin, Berlin, Germany
5Academic Medical Center, Amsterdam, Netherlands
6Ferring Pharmaceuticals, St Prex, Switzerland
5
H. Goldberg1, D. Margel1, L. Shavit-Harunik1, O. Yossepowitch1, D. Kedar1, J. Baniel1, E. Rosenbaum2, I. Kedar3, Z. Levy4, V. Neiman2, B. Brenner2, I. Ben-Aharon2, R. Yerushalmy2, O. Benjaminov5
1Urology, Rabin Medical Center, Israel
2Oncology, Rabin Medical Center, Israel
3Genetics, Rabin Medical Center, Israel
4Gastroenterology, Rabin Medical Center, Israel
5Radiology, Rabin Medical Center, Israel
6
V. Lysenko1, V. Medvedev2, A. Medvedev2, D. Osadchyi1, A. Melenеvky1
1Department of Minimally Invasive Surgery, University Clinic of Odessa National Medical University, Ukraine
2Chair of Urology, Kuban Public Medical University, Russia
7
T. Oliver1, P. Cathcart1, L. Pinney2, J. Cuzick2
1Barts Cancer Institute, Queen Mary University of London, UK
2Wolffson Institute, Queen Mary University of London, UK
8
M. Golovashchenko, B. Alekseev, K. Nyushko, Y. Andreeva, A. Kalpinsky
Urology, Moscow Hertzen Oncology Institute, Russia
9
A. Helfand1,2, O. Yossepowitch1,2, D. Kedar1,2, A. Nadu1,2, R. Ozalvo1,2, J. Baniel1,2, D. Margel1,2
1Department of Urology, Rabin Medical Center, Beilinson Campus, Israel
2Sackler Faculty of Medicine, Tel Aviv University, Israel
10
IS ANEMIA A TRULY ADVERSE PROGNOSTIC FACTOR OF A CHRONIC KIDNEY DISEASE PATIENT WITH UROTHELIAL CARCINOMA OF UPPER URINARY TRACT?
T.H. Lee1, Y.C. Hsieh2, H.C Yah3, K.F. Yang1
1
Urology, Kaohsiung Medical university Chung-Ho MemorialHospital, Taiwan
2Department of Clinical Education and Training, KaohsiungMedical University Chung-Ho Memorial Hospital, Taiwan
3Urology, Kaohsiung Municipal Ta-Tung Hospital, Taiwan
11
H. Yamada1, K. Harta1, K. Tashiro1, S. Bando1, H. Sasaki1, J. Miki2, T. Shimomura1, K. Miki1, S. Egawa1
1Urology, Jikei University School of Medicine, Japan
2Urology, Jikei University School of Medicine, Kashiwa Hospital, Japan
12
R. Mano1, J. Baniel1, O. Yossepowitch1, D. Kedar1, L. Shavit Grievink1,2, E. Rosenbaum2, V. Neiman2, B. Brenner2, O. Purim2, I. Ben-Aharon2, S. Stemmer2, A. Sulkes2, C. Koren2, G. Sabah3, A. Nadu1, D. Margel1,2
1Division of Urology, Rabin Medical Center, Israel
2Oncology, Davidoff Cancer Center, Israel
3Division of Gynecology, Rabin Medical Center, Israel
13
I. Kilemnik1, C. Fiori2, D. Amparore2, F. Porpiglia2
1Medi-tate Ltd., Israel
2Department of Urology, San Luigi Hospital, Italy
14
A. Thomas, V. Sharma, S. Chowdhury
Urology, The Mission Hospital, India
15
K. Aikawa1,2, Y. Hasegawa1,2, M. Honda1, T. Naruoka1, H. Yamada1, T. Kimura1, K. Ueoka2, S. Egawa1
1Urology, Jikei University School of Medicine, Japan
2Urology, National Center for Child Health and Development, Japan
16
C. Florescu1,2, J. Weidenfeld1, O. Portnoy3, Z.A. Dotan4, S. Aviel-Ronen1,5
1Pathology, Sheba Medical Center, Israel
2International Training Fellowship, Sheba Medical Center, Israel
3Diagnostic Imaging, Sheba Medical Center, Israel
4Urology, Sheba Medical Center, Israel
5Talpiot Medical Leadership Program, Sheba Medical Center, Israel
17
Y. Reisman1, A. Hind2, A. Varaneckas3, I. Motil4
1Men's Health Clinic, Amstelland Hospital, Netherlands
2Urology and Andrology Center, Res Crescent Hospital, West Bank
3Urology, Amber Clinic, Lithuania
4Urology, Urologická Ambulance, Czech Republic
18
R.Terlecki, M. Patel
Urology, Wake Forest University, USA

Late additions

19 
METRONOMIC THERAPY FOR STAGE 4 GERM CELL CANCER
A. Neumann,
A. Peer
Rambam Hospital, Haifa, Israel
20
A GENOMIC PROSTATE CANCER CLASSIFIER PREDICTS BIOCHEMICAL FAILURE AND METASTASIS IN PATIENTS FOLLOWING POST-OPERATIVE RADIATION THERAPY
E. Davicioni1,
L. Gomella2, R. Den2, E. Trabulsi2, F. Feng3, K. Yousefi1, M. Ghadessi1, T. Showalter4, M. Mishra5, C. D. Lallas2, K. Kelly2, R. Birbe2, P. McCue2, K. Knudsen2, A. Dicker2
1GenomeDx Biosciences Inc., San Diego, CA
2
Kimmel Cancer Center, Jefferson Medical College of Thomas Jefferson University, Philadelphia, PA
3
University of Michigan, Ann Arbor, MI
4
University of Virginia School of Medicine, Charlottesville, VA
5University of Maryland Medical Center, Baltimore, MD
21
O. Fedotoff5, L. Mikheeva5, B. Zaslavsky5, A. Chait5, J.S. Jones1
1Cleveland Clinic
2
Case Western Reserve University School Of Medicine − Case Medical Center
3
Veterans Administration Boston Healthcare System
4
Biometry Research Group − National Cancer Institute
5Cleveland Diagnostics, Inc.